A detailed history of Ruggaard & Associates LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Ruggaard & Associates LLC holds 4,165 shares of JNJ stock, worth $660,402. This represents 0.31% of its overall portfolio holdings.

Number of Shares
4,165
Previous 4,220 1.3%
Holding current value
$660,402
Previous $661 Million 0.38%
% of portfolio
0.31%
Previous 0.35%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$155.22 - $162.74 $8,537 - $8,950
-55 Reduced 1.3%
4,165 $659 Million
Q4 2023

Feb 15, 2024

SELL
$145.6 - $158.88 $27,372 - $29,869
-188 Reduced 4.26%
4,220 $661 Million
Q3 2023

Nov 09, 2023

SELL
$155.75 - $174.48 $14,017 - $15,703
-90 Reduced 2.0%
4,408 $687 Million
Q2 2023

Aug 10, 2023

SELL
$154.35 - $166.11 $10,187 - $10,963
-66 Reduced 1.45%
4,498 $745 Million
Q1 2023

May 15, 2023

BUY
$151.05 - $180.26 $689,392 - $822,706
4,564 New
4,564 $707 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $415B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Ruggaard & Associates LLC Portfolio

Follow Ruggaard & Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ruggaard & Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ruggaard & Associates LLC with notifications on news.